Research Portal

Research Portal

Hello and welcome to the Bluelight Research Portal! This page has been created to ensure that researchers don't miss an opportunity to work with us in developing their research participation.

 

How can we help?

Are you involved in drug-related research?
Do you need to increase/augment your survey or study enrollment?
Are you a researcher looking to access a large, diverse population of individuals who use drugs such as ecstasy, cannabis, amphetamines, hallucinogens, or novel and emerging substances? Bluelight can help get you access these often hard-to-reach populations.

 

Bluelight is an international message board that educates the public about responsible drug use by promoting free discussion. We advocate harm reduction and attempt to eliminate misinformation. Bluelight is funded by private donations and maintained by a team of volunteers. We have been online since 1999 and currently have a range of approximately 7,000-10,000 active users within any 30 day period.

 

How have we helped in the past?

 

Bluelight works with all kinds of research, from student projects through to large academic grants, from online surveys through to clinical trials, across a large range of drug types and practices, and across multiple world regions. We have helped over 100 researchers access participants over the last 5 years. Our discussions of drug use and harms are also increasingly cited in the scientific literature published on novel and emerging drugs.

 

Some of the more prominent research to which we have directly contributed includes:

 

Chiauzzi, E., DasMahapatra, P., Lobo, K., & Barratt, M. J. (2013). Participatory research with an online drug forum: A survey of user characteristics, information sharing, and harm reduction views. Substance Use and Misuse, 48, 661-670.
Carhart-Harris, R. L., King, L. A., & Nutt, D. J. (2011). A web-based survey on mephedrone. Drug and Alcohol Dependence, 118, 19-22.
Barratt, M. J., Cakic, V., & Lenton, S. (2013). Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review, 32, 141-146.
Ward, J., Rhyee, S., & Plansky, J. (2011). Methoxetamine: a novel ketamine analog and growing health-care concern. Clinical Toxicology, 49, 874-875.


What we can do for you?

 

Some of the services we can provide include:

 

A leadership team familiar with research methodology and protocols
A resident Ph.D. with expertise in drug related research
Promotion of your research project, targeted at your population of interest through our regional forums and our focus forums (where specific drug types are discussions)
Staff who can promote your research through discussions within the community
We curate an online space where you can engage in direct dialogue with your target group, for example, to pilot your study methodology, to engage in collaborative data analysis, and to publish and receive feedback on your findings
A proven track record of driving participant enrollment to exceed research goals
Interested? Please read more and get in touch with our research team

 

Furthermore, we suggest that you read the following two articles, one regarding Bluelight's research standards, and the other, a commitment to our members regarding their privacy, anonymity and safety:

 

Bluelight's Research Standards
Our Pledge to the Bluelight Community


At this point, you have two options: you can either go ahead and create and create a recruitment thread in the Drug Studies Forum, following the recruitment guidelines; or, if you're wanting greater exposure and recruiting power, you can contact us for more details.

 

We wish you the best of luck in your research endeavours and hope that Bluelight can play a part in your success!

  • Published
    May 16, 2019
  • Page views
    6,748
Top